185 related articles for article (PubMed ID: 10872836)
1. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
Hernández M; Pozo L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
[TBL] [Abstract][Full Text] [Related]
2. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
[TBL] [Abstract][Full Text] [Related]
3. Chimeric synthetic peptides from the nucleocapsid p24 protein of human immunodeficiency virus type-1.
Hernández M; Rodríguez I; Pozo L; Rivero J
Biochem Biophys Res Commun; 2001 Mar; 282(1):1-3. PubMed ID: 11263961
[TBL] [Abstract][Full Text] [Related]
4. Chimeric synthetic peptides as antigens for detection of antibodies to HIV-1 and HIV-2.
Shah K; Davis C; Wilson J; Parekh B
East Afr Med J; 1996 Jan; 73(1):63-6. PubMed ID: 8625867
[TBL] [Abstract][Full Text] [Related]
5. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
6. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
8. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of diagnostic efficiency of the recombinant protein modeling immunodominant epitope V3 of envelope gp120 for immunoenzyme detection for HIV-1 infection antibodies].
Riabinina SA; Baranova EN; Sharipova IN; Susekina MI; Puzyrev VF; Obriadina AP; Burkov AN; Ulanova TI
Mol Gen Mikrobiol Virusol; 2007; (3):33-6. PubMed ID: 17886471
[TBL] [Abstract][Full Text] [Related]
10. Use of a chimeric synthetic peptide from the core p19 protein and the envelope gp46 glycoprotein in the immunodiagnosis of HTLV-II virus infection.
Hernández Marin M; Márquez Bocalandro Y; Vallejo RV; Rodríguez Tanty C; Higginson Clark D; Pozo Peña L; Silva León C
Prep Biochem Biotechnol; 2003 Feb; 33(1):29-38. PubMed ID: 12693813
[TBL] [Abstract][Full Text] [Related]
11. Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein.
Ye L; Sun Y; Lin J; Bu Z; Wu Q; Jiang S; Steinhauer DA; Compans RW; Yang C
Virology; 2006 Aug; 352(1):74-85. PubMed ID: 16725170
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity comparison of a multi-antigenic peptide bearing V3 sequences of the human immunodeficiency virus type 1 with TAB9 protein in mice.
Cruz LJ; Quintana D; Iglesias E; Garcia Y; Huerta V; Garay HE; Duarte C; Reyes O
J Pept Sci; 2000 May; 6(5):217-24. PubMed ID: 10823490
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of synthetic peptides for the detection of antibodies against human immunodeficiency virus].
Lottersberger J; Salvetti JL; Tonarelli G
Rev Argent Microbiol; 2003; 35(3):149-55. PubMed ID: 14587377
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of a self-assembling peptide derived from the envelope proteins of HIV type 1. An approach to heterovalent immunogens.
Tripathy SP; Kumar A; Manivel V; Panda SK; Rao KV
J Immunol; 1992 Jun; 148(12):4012-20. PubMed ID: 1534827
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.
Barin F; Meyer L; Lancar R; Deveau C; Gharib M; Laporte A; Desenclos JC; Costagliola D
J Clin Microbiol; 2005 Sep; 43(9):4441-7. PubMed ID: 16145089
[TBL] [Abstract][Full Text] [Related]
17. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 subtype E envelope recombinant peptides containing naturally immunogenic epitopes.
Chang SY; Vithayasai V; Vithayasai P; Essex M; Lee TH
J Infect Dis; 2000 Aug; 182(2):442-50. PubMed ID: 10915074
[TBL] [Abstract][Full Text] [Related]
19. The use of synthetic peptides in the diagnosis of HIV infections.
Petrov RV; Khaitov RM; Sidorovich IG; Pavlikov SP; Nikolaeva IA; Ivachenko ME; Andreev SM; Sklyarov LYu
Biomed Sci; 1990 Mar; 1(3):239-44. PubMed ID: 2103826
[TBL] [Abstract][Full Text] [Related]
20. Antigenic properties of recombinant envelope glycoproteins derived from T-cell-line-adapted isolates or primary human immunodeficiency virus isolates and their relationship to immunogenicity.
Brand D; Lemiale F; Thibault G; Verrier B; Lebigot S; Roingeard P; Buzelay L; Brunet S; Barin F
Virology; 2000 Jun; 271(2):350-62. PubMed ID: 10860888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
